Search

everythinglearnresearchcommunity

for

Search:↓

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Pustules in toxic erythema are linked to hair follicles or sweat ducts.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Most child skin problems during the COVID-19 lockdown were not emergencies and could have been handled by teleconsultation.

There may be a link between Helicobacter pylori infection and the skin condition pityriasis versicolor.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

Oxidative stress is likely important in causing telogen effluvium, and antioxidants might help treat it.

Most hospitalized children with skin issues were boys, with allergic skin diseases like atopic dermatitis being most common, and treatments were usually topical.

Stopping the antidepressant agomelatine improved hair loss in a patient.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Early diagnosis of hair tourniquet syndrome saved a baby's toe from being lost.

Marking nuts can cause skin irritation and allergies.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Referral rates for anaphylaxis patients improved significantly after implementing guidelines.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

The patient responded well to treatment with no disease progression.

Vitiligo patients should be routinely screened for thyroid disease and, if extensive or prolonged, also for RA, PA, and type 2 diabetes.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

The conclusion is that dermatologists can improve women's skin health but must overcome cultural and economic barriers to do so.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.